HAIC Versus TACE for Large Hepatocellular Carcinoma Staged BCLC A/B.
Status:
Active, not recruiting
Trial end date:
2020-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of hepatic arterial infusion
chemotherapy (HAIC) compared with transarterial chemoembolization (TACE) in patients with
large hepatocellular carcinoma staged BCLC A/B.
Phase:
Phase 3
Details
Lead Sponsor:
Sun Yat-sen University
Collaborators:
Dongguan People's Hospital First Affiliated Hospital, Sun Yat-Sen University First People's Hospital of Foshan Guangzhou No.12 People's Hospital Kaiping Central Hospital